22nd Century Group Inc. (NYSEAMERICAN:XXII) has announced that it has received $8.1 million in net proceeds from the cash exercise of outstanding warrants. Notably, the remaining...
The year 2018 is a great period for 22nd Century Group Inc (NYSEAMERICAN:XXII). The plant biotechnology company is making great strides in reducing the tobacco harm...
Plant biotechnology firm 22nd Century Group Inc (NYSEAMERICAN:XXII) has revealed some updates on the Food and Drug Administration’s (FDA) plans to reduce nicotine levels to non-addictive...
22nd Century Group Inc (NYSEAMERICAN:XXII) has announced the receipt of responses to the nicotine reduction plan of US FDA. These submissions to the FDA is authored...
It was today that 22nd Century Group Inc (NYSEAMERICAN:XXII) disclosed that it had plans underway to expand its proprietary lines of VLN .By exclusively licensing from North...
Anytime from now FTSE Russell (Russell) will reconstitute its equity indexes, an undertaking that will have 22nd Century Group Inc (NYSEAMERICAN:XXII) added to the Russell 2000, Russell...
